CSTL
Price
$32.86Alerts
Change
-$0.54 (-1.62%)
Updated
Nov 20 closing price
Capitalization
993.47M
102 days until earnings call
Intraday BUY SELL Signals
NEO
Price
$14.82Alerts
Change
-$0.27 (-1.79%)
Updated
Nov 20 closing price
Capitalization
2.16B
93 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CSTL vs NEO

CSTL vs NEO Comparison Chart in %
View a ticker or compare two or three
VS
CSTL vs. NEO commentary
Nov 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSTL is a Hold and NEO is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CSTL with price predictions
Nov 20, 2026

CSTL in downward trend: price dove below 50-day moving average on November 13, 2026

CSTL moved below its 50-day moving average on November 13, 2026 date and that indicates a change from an upward trend to a downward trend. In 29 of 32 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for CSTL moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 30 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 81%.

The Moving Average Convergence Divergence Histogram (MACD) for CSTL turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In 32 of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.

The 10-day moving average for CSTL crossed bearishly below the 50-day moving average on November 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CSTL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

CSTL broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Momentum Indicator moved above the 0 level on November 20, 2026. You may want to consider a long position or call options on CSTL as a result. In 83 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 89%.

Following a +1.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where CSTL advanced for three days, in 236 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

The Aroon Indicator entered an Uptrend today. In 200 of 227 cases where CSTL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 88%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 22 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.114) is normal, around the industry mean (67.298). P/E Ratio (-50.812) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.947) is also within normal values, averaging (9.775).

The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. CSTL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 86 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CSTL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

A.I.Advisor
a Summary for NEO with price predictions
Nov 20, 2026

NEO sees MACD Histogram crosses below signal line

NEO saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 12, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 49 instances where the indicator turned negative. In 42 of the 49 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NEO as a result. In 67 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.

NEO moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NEO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for NEO's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +6.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where NEO advanced for three days, in 216 of 277 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

NEO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.754) is normal, around the industry mean (67.298). P/E Ratio (-43.179) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (3.189) is also within normal values, averaging (9.775).

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. NEO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 44 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 72 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NEO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

FUNDAMENTALS RATINGS
CSTL vs NEO: Fundamental Ratings
CSTL
NEO
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
27
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9292
PRICE GROWTH RATING
1..100
4142
P/E GROWTH RATING
1..100
8672
SEASONALITY SCORE
1..100
5044

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CSTL's Valuation (22) in the null industry is in the same range as NEO (27) in the Medical Or Nursing Services industry. This means that CSTL’s stock grew similarly to NEO’s over the last 12 months.

CSTL's Profit vs Risk Rating (100) in the null industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that CSTL’s stock grew similarly to NEO’s over the last 12 months.

CSTL's SMR Rating (92) in the null industry is in the same range as NEO (92) in the Medical Or Nursing Services industry. This means that CSTL’s stock grew similarly to NEO’s over the last 12 months.

CSTL's Price Growth Rating (41) in the null industry is in the same range as NEO (42) in the Medical Or Nursing Services industry. This means that CSTL’s stock grew similarly to NEO’s over the last 12 months.

NEO's P/E Growth Rating (72) in the Medical Or Nursing Services industry is in the same range as CSTL (86) in the null industry. This means that NEO’s stock grew similarly to CSTL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CSTLNEO
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 13 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
79%
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 6 days ago
88%
N/A
COMPARISON
Comparison
Nov 22, 2026
Stock price -- (CSTL: $32.86 vs. NEO: $14.82)
Brand notoriety: CSTL and NEO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CSTL: 63% vs. NEO: 62%
Market capitalization -- CSTL: $993.47M vs. NEO: $2.16B
CSTL [@Medical Specialties] is valued at $993.47M. NEO’s [@Medical Specialties] market capitalization is $2.16B. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The average market capitalization across the [@Medical Specialties] industry is $20.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSTL’s FA Score shows that 1 FA rating(s) are green while NEO’s FA Score has 1 green FA rating(s).

  • CSTL’s FA Score: 1 green, 4 red.
  • NEO’s FA Score: 1 green, 4 red.
According to our system of comparison, both CSTL and NEO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSTL’s TA Score shows that 4 TA indicator(s) are bullish while NEO’s TA Score has 4 bullish TA indicator(s).

  • CSTL’s TA Score: 4 bullish, 6 bearish.
  • NEO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NEO is a better buy in the short-term than CSTL.

Price Growth

CSTL (@Medical Specialties) experienced а -2.75% price change this week, while NEO (@Medical Specialties) price change was -7.49% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -9.90%. For the same industry, the average monthly price growth was -17.15%, and the average quarterly price growth was +16.33%.

Reported Earning Dates

CSTL is expected to report earnings on Mar 04, 2027.

NEO is expected to report earnings on Feb 23, 2027.

Industries' Descriptions

@Medical Specialties (-9.90% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

View a ticker or compare two or three
Interact to see
Advertisement

CSTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSTL has been loosely correlated with GH. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if CSTL jumps, then GH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSTL
1D Price
Change %
CSTL100%
-1.63%
GH - CSTL
54%
Loosely correlated
+0.16%
NEO - CSTL
50%
Loosely correlated
-1.79%
TCMD - CSTL
50%
Loosely correlated
-1.50%
ADPT - CSTL
49%
Loosely correlated
-0.43%
NTRA - CSTL
47%
Loosely correlated
-5.70%
More

NEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEO has been loosely correlated with ADPT. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then ADPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEO
1D Price
Change %
NEO100%
-1.79%
ADPT - NEO
55%
Loosely correlated
-0.43%
NTRA - NEO
53%
Loosely correlated
-5.70%
CSTL - NEO
51%
Loosely correlated
-1.63%
GH - NEO
50%
Loosely correlated
+0.16%
RVTY - NEO
46%
Loosely correlated
-4.20%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RDFI21.110.07
+0.36%
Rareview Dynamic Fixed Income ETF (RDFI)
FMQQ11.50-0.11
-0.97%
FMQQ The Next Frontier Internet ETF (FMQQ)
IUS66.26-1.14
-1.69%
Invesco RAFI Strategic US ETF (IUS)
IPB24.27-0.45
-1.84%
Merrill Lynch Depositor
SNTH27.37-0.61
-2.18%
MRP Synthequity ETF